Phi Access Amendment and Disclosure Accounting Sample Clauses

Phi Access Amendment and Disclosure Accounting. A. Within fifteen (15) business days following the request of Covered Entity, Company will: 1. Make available to Covered Entity for inspection and to make copies, any PHI about the individual which Company created or received for or from Covered Entity and that is in the custody of control of the Company as required by 45 C.F.R. §164.524 and, where applicable, the HITECH Act. Company will make such information available in an electronic format where directed by Covered Entity. 2. Make available PHI for amendment or permit Covered Entity access to amend any portion of the PHI which Company created or received for or from Covered Entity, as required by 45 C.F.R. §16.4.526. B. As required by 45 C.F.R. §164.528, Company will record for each disclosure of PHI, not excepted from disclosure accounting below, that Company makes to a third party (item 1-4, collectively “Disclosure Information”); 1. The disclosure date 2. The name and (if known) address of the person or entity whom Company made the disclosure 3. A Brief description of the PHI disclosed 4. A brief statement of the purpose of the disclosure Company further will provide any additional information to the extent required by the HITECH Act, the Final Rules and any accompanying regulations. For repetitive disclosures Company makes to the same person or entity for a single purpose, Company will provide: i. The disclosure information for the first of these repetitive disclosures ii. The frequency or number of these repetitive disclosures iii. The date of the last of these repetitive disclosures disclosure tracking information or otherwise account for disclosure of PHI that this Exhibit or Covered Entity, in writing, permits or requires: 1. For the purpose of Covered Entity’s payment activities or health care operations (except where such recording or accounting is required by the HITECH Actor the Final Rules and as of the effective dates for these provisions); 2. For the purpose of health care providers’ treatment activities, or (other) covered entities’ payment activities or certain health care operations (as set forth in 45 C.F.R. §164.506(c)(4) 3. To the Individual who is the subject of the PHI disclosed 4. Which are incidental to a use or disclosure otherwise permitted or required 5. Pursuant to an authorization 6. To persons involved in that Individual’s care 7. For notification for disaster relief purposes 8. For national security or intelligence purposes 9. To correctional institutions or law enforcem...
Sample 1
Phi Access Amendment and Disclosure Accounting. BA agrees to: A. Provide access, at the request of County, within five (5) days, to PHI in a Designated Record Set, to the County, or to an Individual as directed by the County. If BA maintains an Electronic Health Record, BA shall provide such information in electronic format to enable County to fulfill its obligations under the HITECH Act, including, but not limited to, 42 USC Section 17935(e). B. Within ten (10) days of receipt of a request from County, incorporate any amendments or corrections to the PHI in accordance possession constitutes a Designated Record Set. C. To assist County in meeting its disclosure accounting under HIPAA: (1) BA agrees to implement a process that allows for an accounting to be collected and maintained by BA and its agents or subcontractors for at least six (6) years prior to the request. However, accounting of disclosure from Electronic Health Record for treatment, payment, or health care operations purposes are required to be collected and maintained for only three (3) years prior to the request, and only to the extent that BA maintains an electronic health record and is subject to this requirement. At the minimum, the information collected shall include: (i) the date of disclosure; (ii) the name of the entity or person who received PHI and, if know, the address of the entity or person; (iii) a brief description of PHI disclosed and; (iv) a brief statement of purpose of the disclosure that reasonably informs the individual of the basis for the disclosure, or a copy of the disclosure. (2) Within in 30 days of notice by County, XX agrees to provide to County information collected in accordance with this section to permit the County to respond to a request by an Individual for an accounting of disclosures of PHI. D. Make available to the County, or to the Secretary of Health and and records relating to the use of and disclosure of PHI for subject to any applicable legal restrictions. BA shall provide County a copy of any PHI that BA provides to the Secretary concurrently with providing such information to the Secretary.
Sample 1
Phi Access Amendment and Disclosure Accounting. A. Within fifteen (15) days following the request of Covered Entity, Agent will: 1. Make available to Covered Entity or, at the direction of Covered Entity, to the individual, for inspection and to make copies, any PHI about the individual which Agent created or received for or from Covered Entity and that is in the custody of control of the Agent as required by 45 C.F.R. §164.524 and, where applicable, the HITECH Act. Agent will make such information available in an electronic format where directed by Covered Entity. 2. Make available PHI for amendment or permit Covered Entity access to amend any portion of the PHI which Agent created or received for or from Covered Entity, as required by 45 C.F.R. §16.4.526. B. As required by 45 C.F.R. §164.528, Agent will record for each disclosure of PHI, not excepted from disclosure accounting below, that Agent makes to a third party (item 1-4, collectively “Disclosure Information”); 1. The disclosure date 2. The name and (if known) address of the person or entity whom Agent made the disclosure 3. A Brief description of the PHI disclosed 4. A brief statement of the purpose of the disclosure Agent further will provide any additional information to the extent required by the HITECH Act, the Final Rules and any accompanying regulations. For repetitive disclosures Agent makes to the same person or entity for a single purpose, Agent will provide: i. The disclosure information for the first of these repetitive disclosures ii. The frequency or number of these repetitive disclosures iii. The date of the last of these repetitive disclosures C. Agent will make disclosure-tracking information available to Covered Entity within fifteen (15) days from the date Covered Entity made the request. Agent need not record disclosure tracking information or otherwise account for disclosure of PHI that this Addendum or Covered Entity, in writing, permits or requires: 1. For the purpose of Covered Entity’s payment activities or health care operations (except where such recording or accounting is required by the HITECH Actor the Final Rules and as of the effective dates for these provisions); 2. For the purpose of health care providers’ treatment activities, or (other) covered entities’ payment activities or certain health care operations (as set forth in 45 C.F.R. §164.506(c)(4) 3. To the Individual who is the subject of the PHI disclosed 4. Which are incidental to a use or disclosure otherwise permitted or required 5. Pursuant to an authori...
Sample 1
Phi Access Amendment and Disclosure Accounting 
Sample 1Sample 2Sample 3See All (6)

Related to Phi Access Amendment and Disclosure Accounting

  • Permitted Uses and Disclosures of PHI and the third party notifies the Business Associate of any instances of which it is aware in which the confidentiality of the information has been breached.

  • CERTIFICATION AND DISCLOSURE REGARDING PAYMENTS TO INFLUENCE CERTAIN FEDERAL TRANSACTIONS (SEP 2007). This clause applies only if this contract exceeds (i) $100,000 if included in

  • PERMITTED USES AND DISCLOSURES BY CONTRACTOR Except as otherwise limited in this Schedule, Contractor may use or disclose Protected Health Information to perform functions, activities, or services for, or on behalf of, County as specified in the Agreement; provided that such use or disclosure would not violate the Privacy Rule if done by County.

  • Permitted Uses and Disclosures by Business Associate Except as otherwise limited by this Agreement, Business Associate may make any uses and disclosures of Protected Health Information necessary to perform its services to Covered Entity and otherwise meet its obligations under this Agreement, if such use or disclosure would not violate the Privacy Rule if done by Covered Entity. All other uses or disclosures by Business Associate not authorized by this Agreement or by specific instruction of Covered Entity are prohibited.

  • Permitted Uses and Disclosures of Phi by Business Associate Except as otherwise indicated in this Agreement, Business Associate may use or disclose PHI, inclusive of de-identified data derived from such PHI, only to perform functions, activities or services specified in this Agreement on behalf of DHCS, provided that such use or disclosure would not violate HIPAA or other applicable laws if done by DHCS.

  • Records Audit and Disclosure 5.01 Access to records, books, and documents 5.02 Response/compliance with audit or inspection findings A. At Performing Agency's sole expense, Performing Agency must take action to ensure its or a Subcontractor’s compliance with a correction of any finding of noncompliance with any law, regulation, audit requirement, or generally accepted accounting principle relating to the Services and Deliverables or any other deficiency contained in any audit, review, or inspection conducted under the Contract. Whether Performing Agency's action corrects the noncompliance shall be solely the decision of the System Agency. B. As part of the Services, Performing Agency must provide to HHSC upon request a copy of those portions of Performing Agency's and its Subcontractors' internal audit reports relating to the Services and Deliverables provided to the State under the Contract.

  • Identification and Disclosure of Privacy and Security Offices Business Associate and Subcontractors shall provide, within ten (10) days of the execution of this agreement, written notice to the Covered Entity’s contract/grant manager the names and contact information of both the HIPAA Privacy Officer and HIPAA Security Officer. This information must be updated any time either of these contacts changes.

  • Accounting and Disclosure Controls The Company and its subsidiaries have taken all actions necessary to ensure that, within the time period required by applicable law, the Company will have established and will maintain effective “internal control over financial reporting” (as defined in Rule 13a-15 of the 1934 Act Regulations). The Company and its subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that (A) transactions are executed in accordance with management’s general or specific authorizations; (B) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability; (C) access to assets is permitted only in accordance with management’s general or specific authorization; and (D) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. Except as described in the Registration Statement, the General Disclosure Package and the Prospectus, since the first day of the Company’s earliest fiscal year for which audited financial statements are included or incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus, there has been (1) no material weakness (as defined in Rule 1-02 of Regulation S-X of the Commission) in the Company’s internal control over financial reporting (whether or not remediated), and (2) no fraud, whether or not material, involving management or other employees who have a role in the Company’s internal control over financial reporting and, since the end of the Company’s earliest fiscal year for which audited financial statements are included or incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus, there has been no change in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting. The Company and its subsidiaries have established, maintained and periodically evaluate the effectiveness of “disclosure controls and procedures” (as defined in Rules 13a-15 of the 1934 Act Regulation and 15d-15 under the 1934 Act); such disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company in the reports that it will be required to file or submit under the 1934 Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms, and is accumulated and communicated to the Company’s management, including its principal executive officer or officers and principal financial officer or officers, as appropriate, to allow timely decisions regarding disclosure. The Company’s independent public accountants and the audit committee of the Company’s board of directors have been advised of all material weaknesses, if any, and significant deficiencies (as defined in Rule 1-02 of Regulation S-X of the Commission), if any, in the Company’s internal control over financial reporting and of all fraud, if any, whether or not material, involving management or other employees who have a role in the Company’s internal control over financial reporting, in each case that occurred or existed, or was first detected at any time during the three most recent fiscal years covered by the Company’s audited financial statements included in the Registration Statement, the General Disclosure Package and the Prospectus or at any time subsequent thereto.

  • Permitted Uses and Disclosure by Business Associate (1) General Use and Disclosure Provisions Except as otherwise limited in this Section of the Contract, Business Associate may use or disclose PHI to perform functions, activities, or services for, or on behalf of, Covered Entity as specified in this Contract, provided that such use or disclosure would not violate the HIPAA Standards if done by Covered Entity or the minimum necessary policies and procedures of the Covered Entity.

  • Press Releases and Disclosure The Company may issue a press release describing the material terms of the transactions contemplated hereby as soon as practicable following the date of this Agreement, and may file with the Commission a Current Report on Form 8-K, with this Agreement attached as an exhibit thereto, describing the material terms of the transactions contemplated hereby, and the Company shall consult with the Agent prior to making such disclosures, and the parties hereto shall use all commercially reasonable efforts, acting in good faith, to agree upon a text for such disclosures that is reasonably satisfactory to all parties hereto. No party hereto shall issue thereafter any press release or like public statement (including, without limitation, any disclosure required in reports filed with the Commission pursuant to the Exchange Act) related to this Agreement or any of the transactions contemplated hereby without the prior written approval of the other party hereto, except as may be necessary or appropriate in the reasonable opinion of the party seeking to make disclosure to comply with the requirements of applicable law or stock exchange rules. If any such press release or like public statement is so required, the party making such disclosure shall consult with the other party prior to making such disclosure, and the parties shall use all commercially reasonable efforts, acting in good faith, to agree upon a text for such disclosure that is reasonably satisfactory to all parties hereto.